Added to YB: 2025-06-17
Pitch date: 2025-06-14
NXGL [neutral]
NEXGEL, Inc.
-36.9%
current return
Author Info
Ahead of the Curve focuses on identifying and owning great small cap companies. Sign up for the newsletter.
Company Info
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Market Cap
$12.2M
Pitch Price
$2.52
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.74
P/E
-3.97
EV/Sales
1.27
Sector
Health Care Equipment and Supplies
Category
growth
Taking Stock, Recalibrating, and Signing Off: Current Portfolio - NEXGEL, Inc.
NXGL (holding update): Biomedical hydrogel company growing 100% YoY, targeting $15M 2025 revenue (1.25x sales). Recent traction: Silly George beauty line hit $5M ARR; SilverSeal shipping to Cintas; iRhythm deal; STADA expanding beyond Histasolv. $1.2M cash, likely breakeven Q3, no dilution needed. Stock down on AbbVie delays & tariff fears.
Read full article (5 min)